- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
AI-Fueled COVID-19 Detection Algorithm Slices Report Time 30 Percent
RADLogics’ CEO Moshe Becker discusses the potential role of the chest CT AI tool and the impact it could make into the future.
A radiology workflow artificial intelligence (AI) solution from RADLogics can help providers truncate their turn-around time for COVID-19 detection cases by up to 30 percent, according to a recently released study.
According to a clinical trial conducted at the Moscow Center for Diagnostics & Telemedicine, employing this AI solution to evaluate chest CT scans can shave 7 minutes off the time needed to produce a radiology report.
The study included 128,350 chest CT scans – 36,358 of which were assessed with the RADLogics algorithm – as well as 570 radiologists from more than 130 hospitals and outpatient facilities. The results were discussed earlier this month during ECR 2021.
Diagnostic Imaging spoke with Moshe Becker, chief executive officer and co-founder of RADLogics, about what makes this algorithm unique for use during the pandemic, as well as what benefits it provides for both radiologists and patients. In addition, he pointed to how the tool can be used as more vaccines are administered and the pandemic, potentially, begins to dissipate.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
